BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19194466)

  • 1. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.
    Haferlach T; Kohlmann A; Klein HU; Ruckert C; Dugas M; Williams PM; Kern W; Schnittger S; Bacher U; Löffler H; Haferlach C
    Leukemia; 2009 May; 23(5):934-43. PubMed ID: 19194466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic Characteristics of de novo Acute Myeloid Leukemia in Southern Vietnam.
    Thao LTT; Ha CT; Ha NTT; Beaupha SMC; Nghia H; Tung TT; Son NT; Binh NT; Dung PC; Vu HA; Xinh PT
    Asian Pac J Cancer Prev; 2023 May; 24(5):1789-1795. PubMed ID: 37247302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [EVI1 expression, clinical and cytogenetical characteristics in 447 patients with acute myeloid leukemia].
    He XF; Wang QR; Cen JN; Qiu HY; Sun AN; Chen SN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):936-941. PubMed ID: 27995876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML).
    Krali O; Palle J; Bäcklin CL; Abrahamsson J; Norén-Nyström U; Hasle H; Jahnukainen K; Jónsson ÓG; Hovland R; Lausen B; Larsson R; Palmqvist L; Staffas A; Zeller B; Nordlund J
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia with rare recurring translocations-an overview of the entities included in the international consensus classification.
    Rørvik SD; Torkildsen S; Bruserud Ø; Tvedt THA
    Ann Hematol; 2024 Apr; 103(4):1103-1119. PubMed ID: 38443661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.
    Kühnl A; Valk PJ; Sanders MA; Ivey A; Hills RK; Mills KI; Gale RE; Kaiser MF; Dillon R; Joannides M; Gilkes A; Haferlach T; Schnittger S; Duprez E; Linch DC; Delwel R; Löwenberg B; Baldus CD; Solomon E; Burnett AK; Grimwade D
    Blood; 2015 May; 125(19):2985-94. PubMed ID: 25805812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy.
    Ananthaneni A; Benzar T; Hafiz N; Akabane H
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36977512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive review of adult acute myelogenous leukemia: cytomorphological, enzyme cytochemical, flow cytometric immunophenotypic, and cytogenetic findings.
    Dunphy CH
    J Clin Lab Anal; 1999; 13(1):19-26. PubMed ID: 10025733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new adult AML case with an extremely complex karyotype, remission and relapse combined with high hyperdiploidy of a normal chromosome set in secondary AML.
    Wafa A; ALmedania S; Aljapawe A; Liehr T; Soulaiman SE; Mouna R; Othman MAK; ALachkar W
    BMC Hematol; 2018; 18():21. PubMed ID: 30186609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets.
    Ragusa D; Dijkhuis L; Pina C; Tosi S
    Biosci Rep; 2023 Jan; 43(1):. PubMed ID: 36622782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The power and potential of integrated diagnostics in acute myeloid leukaemia.
    Haferlach T; Schmidts I
    Br J Haematol; 2020 Jan; 188(1):36-48. PubMed ID: 31808952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLEC11A methylation is correlated to AML subtypes and cytogenetic risk factors but not patient demographics.
    Swanson AJ; Rogowski VJ; Bishop JA; Walker DM; Roxas GM; Raimondi SL
    PLoS One; 2024; 19(3):e0300477. PubMed ID: 38466706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research.
    Skopek R; Palusińska M; Kaczor-Keller K; Pingwara R; Papierniak-Wyglądała A; Schenk T; Lewicki S; Zelent A; Szymański Ł
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic pathways leading to therapy-related myeloid neoplasms.
    Stoddart A; McNerney ME; Bartom E; Bergerson R; Young DJ; Qian Z; Wang J; Fernald AA; Davis EM; Larson RA; White KP; Le Beau MM
    Mediterr J Hematol Infect Dis; 2011; 3(1):e2011019. PubMed ID: 21713073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis.
    Diab A; Zickl L; Abdel-Wahab O; Jhanwar S; Gulam MA; Panageas KS; Patel JP; Jurcic J; Maslak P; Paietta E; Mangan JK; Carroll M; Fernandez HF; Teruya-Feldstein J; Luger SM; Douer D; Litzow MR; Lazarus HM; Rowe JM; Levine RL; Tallman MS
    Leuk Res; 2013 Jan; 37(1):32-6. PubMed ID: 23102703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
    Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
    Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
    Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
    J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.
    Xie W; Hu S; Xu J; Chen Z; Medeiros LJ; Tang G
    Ann Hematol; 2019 May; 98(5):1149-1157. PubMed ID: 30759270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Classification and Prognosis in Acute Myeloid Leukemia.
    Papaemmanuil E; Gerstung M; Bullinger L; Gaidzik VI; Paschka P; Roberts ND; Potter NE; Heuser M; Thol F; Bolli N; Gundem G; Van Loo P; Martincorena I; Ganly P; Mudie L; McLaren S; O'Meara S; Raine K; Jones DR; Teague JW; Butler AP; Greaves MF; Ganser A; Döhner K; Schlenk RF; Döhner H; Campbell PJ
    N Engl J Med; 2016 Jun; 374(23):2209-2221. PubMed ID: 27276561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.
    Borrow J; Stanton VP; Andresen JM; Becher R; Behm FG; Chaganti RS; Civin CI; Disteche C; Dubé I; Frischauf AM; Horsman D; Mitelman F; Volinia S; Watmore AE; Housman DE
    Nat Genet; 1996 Sep; 14(1):33-41. PubMed ID: 8782817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.